Long-term increase in serum cholesterol levels in ulcerative colitis patients treated with cyclosporine: An underdiagnosed side effect frequently associated with other drug-related complications

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 1, 2014, Pages 59-65

  Bálint, Anita ^a   Farkas, Klaudia ^a   Szucs, Mónika ^a   Szepes, Zoltán ^a   Nagy, Ferenc ^a   Wittmann, Tibor ^a   Molnár, Tamás ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cholesterol; Cyclosporine; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CREATININE; CYCLOSPORIN; INFLIXIMAB; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALOPECIA; ARTICLE; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPERTRIGLYCERIDEMIA; INFECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MIDDLE AGED; MUSCLE CRAMP; MYALGIA; NAIL INFECTION; NEPHROTOXICITY; NEURITIS; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; SKIN MANIFESTATION; TREATMENT DURATION; TREMOR; TRIACYLGLYCEROL BLOOD LEVEL; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; VOMITING; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CHOLESTEROL; COLITIS, ULCERATIVE; CREATININE; CYCLOSPORINE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPERTRIGLYCERIDEMIA; HYPESTHESIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYALGIA; PROSPECTIVE STUDIES; TIME FACTORS; TREMOR; YOUNG ADULT;

EID: 84890922334     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.848231     Document Type: Article

References (26)

1. Holme O, Thiis-Evensen E, Vatn MH. Treatment of fulminant ulcerative colitis with cyclosporine A. Scand J Gastroenterol 2009;44: 1310-14
2. Travis SP, Stange EF, Lémann M, Oresland T, Bemelman WA, Chowers Y, et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis 2008;2: 24-62
3. Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: A parallel, open-label randomised controlled trial. Lancet 2012;380: 1909-15
4. Chang KH, Burke JP, Coffey JC. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: A systematic review and meta-analysis. Int J Colorectal Dis 2013;28: 287-93
5. Cheifetz A, Stern J, Garud S, Goldstein E, Malter L, Moss AC, et al. Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis. J Clin Gastroenterol 2011;45: 107-12
6. Kobayashi T, Naganuma M, Okamoto S, Hisamatsu T, Inoue N, Ichikawa H, et al. Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis. J Gastroenterol 2010;45: 1129-37
7. Durai D, Hawthorne AB. Review article: How and when to use ciclosporine in ulcerative colitis. Aliment Pharmacol Ther 2005;22: 907-16
8. Maza A, Montaudié H, Sbidian E, Gallini A, Aractingi S, Aubin F, et al. Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol 2011;25: 19-27
9. Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM Jr, et al. Effects of Cyclosporine Therapy on Plasma Lipoprotein Levels. JAMA 1989;262: 53-6
10. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999;5: 1-10
11. Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, et al. Randomized, Double-Blind Comparison of 4 mg/kg Versus 2 mg/kg Intravenous Cyclosporine in Severe Ulcerative Colitis. Gastroenterology 2003;125: 1025-31
12. Siew C Ng, Kamm MA. Therapeutic Strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009;15: 935-50
13. Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; GETECCU. The GETECCU clinical guideline for the treatment of ulcerative colitis: A guideline created using GRADE methodology. Gastroenterol Hepatol; Article in press
14. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N EnglJMed 1994;30: 1841-5
15. Weber A, Fein F, Koch S, Dupont-Gossart AC, Mantion G, Heyd B, et al. Treatment of Ulcerative Colitis Refractory to Steroid Therapy by Oral Microemulsion Cyclosporine (Neoral). Inflamm Bowel Dis 2006;12: 1131-5
16. Kuster GM, Drexel H, Bleisch JA, Rentsch K, Pei P, Binswanger U, et al. Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 1994;57: 1479-83
17. Reed RM, Hashmi S, Eberlein M, Iacono A, Netzer G, DeFilippis A, et al. Impact of lung transplantatioNon serum lipids in COPD. Respir Med 2011;105: 1961-8
18. Ragheb A, Attia A, Elbarbry F, Prasad K, Shoker A. Attenuated Combined Action of Cyclosporine A and Hyperlipidemia on Atherogenesis in Rabbits by Thymoquinone. Evid Based Complement Alternat Med 2011
19. Spinelli GA, Felipe CR, park SI, Mandia-Sampaio EL, Tedesco-Silva H Jr, Madina-Pestana JO. Lipid Profile Changes During the First Year After Kidney Transplantation: Risk Factrors and Influence of the Immunosuppressive Drug Regimen. Transplant Proc 2011;43: 3730-7
20. Azer SA, Stacey NH. Differential effects of cyclosporin A on the transport of bile acids by human hepatocytes. Biochem Pharmacol 1993;45: 813-19
21. Hulzebos VC, Bijleveld CM, Stellaard F, Fidler V, Slooff MJ, Peeters PM, et al. Cyclosporine A-induced reduction of bile salt synthesis associated with increased plasma lipids in children after liver transplantation. Liver Transpl 2004;10: 872-80
22. Wang J, Zhang ZR, Chou CF, Liang YY, Gu Y, Ma HP. Cyclosporine stimulated the renal epithel sodium channel by elevating cholesterol. Am J Physiol Renal Physiol 2009;296: 284-90
23. 3Zheng XL, Wong NCW. Cyclosporin A inhibits apolipoprotein AI gene expression. J Mol Endocrinol 2006;37: 367-73
24. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, et al. Utility of different lipid measuresfor prediction of coronary heart disease in men and women. JAMA 2007;298: 776-85; Reprinted
25. Suk HY, Zhou C, Yang TT, Zhu H, Yu RY, Olabisi O, et al. Ablation of calcineurin Ab reveals hyperlipidemia and signaling crosstalks with phosphodiesterases. J Biol Chem 2012; Epub ahead of print
26. Charco RR, Cantarell C, Vargas V, Capdevila L, Lazaro JL, Hidalgo E, et al. Serum cholesterol changes in long-term survivors of liver transplantation: A comparison between cyclosporine and tacrolimus therapy. Liver Transpl Surg 1999;5: 204-8